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Abstract
Staphylococcus aureus, Coagulase-negative staphylococci, and Enterococci sp. are the usual
pathogens involved in nosocomial bacterial endocarditis. Corynebacterium species isolation in
blood specimens is usually considered to be a contaminant. We present an interesting case of
native mitral valve endocarditis in a 73 year old African American female that was diagnosed days
after she was discharged from our institution. The infection was cleared with medical therapy alone.
Introduction
Over the past twenty years, the epidemiological profile of
infective endocarditis has been changing. [1] The number
of cases of hospital-acquired endocarditis has been
increasing. This entity carries a higher mortality rate com-
pared with community-acquired cases. Indwelling cathe-
ters, intravenous lines, intravascular procedures and
devices have increased the risk of bacteriemia. [2] The
presentation is not always evident and especial impor-
tance should be given to the clinical history in a patient
with fever and no evident source of infection. Positive
blood cultures for Corynebacterium species, and Coryne-
bacterium striatum in particular, should never be over-
looked.
Case report
This is a case of a 73-year-old African American female
with a history of hypertension, chronic kidney disease,
diastolic congestive heart failure and diabetes mellitus
who consulted to the Emergency Service with three-day
history of fevers, chills and fatigue. The patient was dis-
charged home 15 days prior to this admission after a 9-
day hospitalization where she received treatment for an
exacerbation of her heart failure. Vital signs on this admis-
sion: Temperature of 102.4 F, Blood pressure of 170/68
mm Hg, Heart Rate of 100 beats per minute, Respiratory
Rate of 20 breaths per min., and Oxygen Saturation of
98% on 3 liters nasal canula. Physical examination
revealed a new 3/6 non-radiating systolic murmur at the
apex. Auscultation of the lungs revealed clear breath
sounds and inspection of lower extremities showed trace
edema bilaterally. Basic metabolic panel and complete
blood cell count was ordered (table 1). The patient was
started on broad spectrum coverage with Vancomycin and
Cefepime; due her previous admission, she was treated as
she was having a nosocomial infection. Two sets of blood
cultures drawn on admission grew CS in both the aerobic
and anaerobic bottles sensitive to vancomycin (table 2).
In order to distinguish CS from other Corynebacterium
species, a metabolic profile obtained in the bioMerieux
data base (version 2.0) was applied. Surveillance cultures
were negative on day 6. A trans-thoracic echocardiogram
showed asymmetric shaggy densities on the mitral valve,
suggesting possible vegetations. The Doppler study
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revealed mild to moderate mitral regurgitation, and a nor-
mal ejection fraction alone with an abnormal diastolic
compliance of the left ventricle. A similar study done on
the previous admission did not reveal any foreign mate-
rial or valvular damage. A subsequent trans-esophageal
echocardiogram confirmed the presence of a 2.9 × 0.5 cm
echo densities indicating mitral valve endocarditis with
possible small eccentric perforation of the valve. The
patient received a six-week course of intravenous Vanco-
mycin, dosed according to through blood levels with a tar-
get of 15–20 ug/ml, and became afebrile. She recovered
and was finally discharged home. Surgical repair of the
mitral valve was offered, which she adamantly refused. A
surveillance echocardiogram done after treatment unfor-
tunately showed findings consistent with moderate pul-
monary hypertension and a persistent mitral
regurgitation.
Discussion
Two of the Duke major criteria were met, including the
microbiology and echocardiographic findings, making a
definitive diagnosis. [3] There is neither a recognized
standard method nor specific MIC breakpoints or guide-
lines published by NICCS for antimicrobial testing of
coryneform bacteria. National Committee for Clinical
Laboratory Standards interpretive criteria currently valid
for staphylococci, streptococci, or listeria monocytogenes
was applied. Chester in 1901 and then Eberson in 1918
described for the first time the Striatum strain, and since
then numerous corynebacterium species have been iden-
tified and reclassified, in different strains. [4]
In the 1980s and 1990s CS infections have been disre-
garded. It was only until recently that Corynebacterium
diphtheria was considered to be the only pathogen of the
coryneform species. Today, other species, such as C.
jeikeium, C. urealiticum, C. amycolatum along with CS,
are recognized as emerging hospital pathogens. The path-
ogenicity in non-diphtheriae corynebacteria species isn't
well-known. Neither toxin nor other virulence factors
explain the transition from colonization to infection. [5]
Martin et al. isolated identical strains of CS from a leg
ulcer and from the bloodstream in a patient with periph-
eral vascular disease, confirming the entry of the bacte-
rium through the skin to the circulation. [6] The spectrum
of diseases generated by CS is extensive, going from men-
ingitis, keratitis, to arthritis, among others. [5]
The spread of CS from patient to patient and nosocomial
outbreaks have been documented. Leonard et al., Iaria et
al., and Brandenbrug described outbreaks caused by a sin-
gle strain in intensive care unit settings. Leonard et al.,
described a selective pressure due to prior exposure to
antibiotics favoring the overgrowth of CS in immune defi-
cient patients. Brandenbrug et al recovered the strain in
the air around infected patients and on the hands of the
housestaff. [7-9]. Vancomycin is still the drug of choice for
many authors since in vitro resistance has not been
showed for this or any other Corynebacterium species.
The spread of multidrug resistance strains of CS is con-
cerning, although the mechanisms are not cleared. Ten
years ago, CS was still sensitive to beta lactams, fluoroqui-
nolones, carbapenems and linezolid. [10,11]
Conclusion
In the hospital setting, positive blood cultures for Coryne-
bacterium species, and CS in particular, should never be
overlooked. Unlike other hospital-acquired pathogens
such as staphylococcal or enterococcal species, that tend
to infect patients with a predisposing condition such as a
valvulopathy, CS endocarditis can be seen even in patients
without prosthetic valves or structural heart disease. More
research needs to be conducted to evidence what resist-
ance mechanisms are involving this organism. Nowadays
CS is being considered one of the emergent nosocomial
agents implicated in endocarditis and serious infections.
Table 1: Basic metabolic panel and complete blood cell count
Hematology Chemistry
WBC 13.300 Sodium 138 ANA negative
Hemoglobin 8.3 Potasium 4.2 Comp C3 normal
Hematocrit 25 Chloride 109 Comp C4 normal
Platelet 334 BUN 65 Hepatitis panel non-reactive
Creatinine 3.0
Glucose 183
Ref: White blood count (WBC), Blood Urea Nitrogen (BUN).
Table 2: Antibiotic resistance profile
Ampicillin > 4 R
Azithromycin > 2 R
Cefepime > 2 R
Cefotaxime > 2 R
Erythromycin >0.5 R
Meropenem 0.5 S
Vancomycin 0.5 S
Ref: S = SUSCEPTIBLE. I = INTERMEDIATE R = RESISTANT IR = 
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